Concepedia

Matthew Mossanen

MM

Statistics

Publications

50

Citations

1.9K

H-Index

26

Active since

2010

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

University of Washington

Dana-Farber Brigham Cancer Center

Matthew Mossanen is an author at Brigham and Women's Hospital specializing in medicine, surgery, and oncology.

ORCID

Publications per year

2010–2025

50

Publications

50

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

David A. Braun, Giorgia Moranzoni, Vipheaviny Chea et al. · Nature · 2025 · 165 citations · Full text

, , +17

Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy.

Shilpa Gupta, Guru Sonpavde, Christopher Weight et al. · Journal of Clinical Oncology · 2020 · 138 citations

, , +17

An Algorithm Informed by the Parathyroid Hormone Level Reduces Hypocalcemic Complications of Thyroidectomy

James E. Wiseman, Matthew Mossanen, Philip H. G. Ituarte et al. · World Journal of Surgery · 2010 · 110 citations · Full text

, , +16

Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA

Jeffrey J. Leow, Alexander P. Cole, Thomas Seisen et al. · European Urology · 2017 · 83 citations

, , +10

Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic subtype matter?

Sebastian Berg, David D’Andrea, Malte W. Vetterlein et al. · Cancer · 2019 · 76 citations · Full text

, , +17

1–5 of 50